TRIO PHARMACEUTICALS
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
TRIO PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-05-25
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.triopharmaceuticals.com
Total Employee:
1+
Status:
Active
Contact:
+1-765-490-0874
Email Addresses:
[email protected]
Total Funding:
3.73 M USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tech Coast Angels
Tech Coast Angels investment in Seed Round - Trio Pharmaceuticals
Newsight Tech Angels
Newsight Tech Angels investment in Seed Round - Trio Pharmaceuticals
Purdue Foundry
Purdue Foundry investment in Seed Round - Trio Pharmaceuticals
SeedFolio
SeedFolio investment in Seed Round - Trio Pharmaceuticals
Friedman BioVentures
Friedman BioVentures investment in Seed Round - Trio Pharmaceuticals
Official Site Inspections
http://www.triopharmaceuticals.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Trio Pharmaceuticals"
TRIO Pharmaceuticals | Cancer Therapeutics
TRIO addresses the above problems by developing a novel class of dual targeting antibody drugs that precisely kills cancer cells, overcomes tumor immunosuppression, and allows the body’s …See details»
Trio Pharmaceuticals - Crunchbase Company Profile
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and …See details»
TRIO PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TRIO PHARMACEUTICALS, INC. of Murrieta, CA. Get the latest business insights from Dun & …See details»
TRIO Pharmaceuticals, Inc. | LinkedIn
TRIO Pharmaceuticals, Inc. | 691 followers on LinkedIn. Outsmart Cancer | We are a cancer therapeutics company with a mission to improve efficacy, reduce toxicity and increase treatment ...See details»
TRIO Pharmaceuticals - Overview, News & Similar companies
TRIO Pharmaceuticals contact info: Phone number: (619) 786-3495 Website: www.triopharmaceuticals.com What does TRIO Pharmaceuticals do? Trio Pharmaceuticals, …See details»
TRIO Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 930 Brittan Avenue . San Francisco, California, United States. 619-786-3495See details»
TRIO Pharmaceuticals | Cancer Therapeutics
Experience cutting-edge cancer treatment with TRIO Pharmaceuticals. Our dual-action antibody-drug conjugates (ADCs), including TRIObody Drug Conjugates (TDC™), revolutionize therapy …See details»
TRIO Pharmaceuticals, Inc. - VentureRadar
Website: https://www.triopharmaceuticals.com/ Develops bispecific antibodies and dual-action immunotherapies that target tumor growth and immunosuppression ...See details»
Aji Bio-Pharma | Trio Pharmaceuticals, Inc. and Ajinomoto Bio …
More information on TRIO Pharmaceuticals, Inc., contact: Shiva Bhowmik, PhD, CEO [email protected] | (765) 490-0874. About Ajinomoto Bio-Pharma Services …See details»
Trio Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Trio Pharmaceuticals is a company that provides Cancer, Health care and more. Trio Pharmaceuticals is headquartered in US CA. Trio Pharmaceuticals was founded in 2018.See details»
triopharmaceuticals.com Reviews: Is this site a scam or legit?
Organization Domains By Proxy, LLC ... In the context of triopharmaceuticals.com, our investigation continues working to pinpoint the specific category, but we welcome your insights …See details»
TRIO Pharmaceuticals - PitchBook
TRIO Pharmaceuticals General Information Description. Developer of a cancer immunotherapeutic antibody drug designed to generate immunogenic tumors. The company's …See details»
Trio Pharmaceuticals - Funding, Financials, Valuation & Investors
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.See details»
Trio Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Trio Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of …See details»
TRIO Pharmaceuticals Completes $3.1 Million Financing Round to …
Dec 3, 2024 SAN DIEGO--(BUSINESS WIRE)-- TRIO Pharmaceuticals, Inc., a biotechnology company pioneering bispecific antibodies for the treatment of cancer with unprecedented …See details»
NuFund Venture Group Invests in TRIO Pharmaceuticals to …
December 3th , 2024– San Diego, CA – NuFund Venture Group (NuFund) is proud to announce its investment in TRIO Pharmaceuticals Inc., a groundbreaking cancer immunotherapeutics …See details»
Trio Pharmaceuticals Company Profile: Overview and Full News …
Triopharmaceuticals.com. Overview: Trio Pharmaceuticals. Trio Pharmaceuticals, based in California, is a cancer therapeutics company focused on developing novel dual targeting …See details»
Trio Pharmaceuticals Raises $2.2 Million Seed
Apr 11, 2023 Trio Pharmaceuticals, Inc. (TRIO) has been bootstrapping the development of its “three arm” approach to treating cancer since its founding – until now. Shiva Bhowmik, Ph.D. …See details»
TRIO Pharmaceuticals Completes $3.1 Million Financing Round to …
Dec 3, 2024 Reiner Laus, MD, CEO +1 650 278 2250 [email protected]. Contacts. Reiner Laus, MD, CEO +1 650 278 2250 [email protected]. Site …See details»
TRIO Pharmaceuticals Secures $3.1M - San Diego Business Journal
Dec 17, 2024 SAN DIEGO – Local biotech firm TRIO Pharmaceuticals, Inc. scored an additional $3.1 million in funding to advance its novel “dual-targeting” approach to treating cancer. The …See details»